Theramex’s Sustainability Report 2023

About this report

Welcome to Theramex’s first sustainability report, which sets out our priorities as a global pharmaceutical company committed to supporting women’s healthcare.

In this report, we share our ambitions for pursuing positive impacts on people, planet and business performance, and give a progress update for the calendar year 2023. While all metrics relate to 2023, we also describe some activities and plans from 2024 for completeness. Our reporting will fully align with the calendar year in future.

Our reporting covers all Theramex operations and markets, and aligns with the Sustainability Accounting Standards Board (SASB) Standards for Biotechnology & Pharmaceuticals and for Healthcare Distributors, where relevant to our business model.